Retrogenix has named Matthew Britz as its North American business development director. Britz will operate out of the UK firm's newly established US office in Cambridge, Mass. He previously served as director of business development at Evory Therapeutics and earlier in his career held scientific and managerial positions at Pfizer, Merck, and Acambis.
People in the News: Matthew Britz
Jun 28, 2014